About: LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.45 (-4.26%)
LTP ASX LTR Pharma Ltd
Loading watchlist status…
LTR Pharma Ltd share price
LTP price activity
Last Price
$0.450
Change (24hr)
-0.02 AUD (4.26%)
Volume
112.33K
Volume (4w avg)
-
Open
$0.48
Day Range
$0.45 - $0.48
Previous Close
$0.47
Last Trade
12 Nov, 4:42 am GMT+0
Delayed
12 Nov, 4:42 am GMT+0
LTP price performance
+7.14%
5D
-5.26%
1M
-37.50%
YTD
-8.16%
1Y
Delayed
12 Nov, 4:42 am GMT+0
LTP details
LTP Market Signals